Solara Active Pharma Sciences hit a lower circuit limit of 20% at Rs 775.05 after the company reported consolidated net loss of Rs 139.87 crore in Q3 December 2021 as against net profit of Rs 65.80 crore in Q3 December 2020.
For 9MFY22, the company's Consolidated PAT was up by 59% to Rs1,523 crore versus Rs957 crore in 9MFY21.
Sales rise 4.13% to Rs 75.72 crore
FAITH, the policy federation of all the ten national associations representing the complete tourism, travel and hospitality industry of India - ADTOI, ATOAI, FHRAI, HAI, IATO, ICPB, IHHA, ITTA, TAAI & TAFI has written to NITI Aayog for immediate support.
Airtel Xstream Premium launch, unlocks the exciting world of Video Streaming entertainment, for India’s growing tribe of digitally connected customers, with its latest launch addressing just what they wanted.
Sales rise 9.59% to Rs 115.18 crore
Mars Medical Devices received a license for the complete range of Joint replacement from Shalby Advanced Technologies Inc. USA.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
